The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prediction of benefit from treatment beyond the first line in patients with metastatic breast cancer (MBC).
Marta Bonotto
No relevant relationships to disclose
Lorenzo Gerratana
No relevant relationships to disclose
Alessandro Minisini
No relevant relationships to disclose
Elena Poletto
No relevant relationships to disclose
Stefania Russo
No relevant relationships to disclose
Claudia Andreetta
No relevant relationships to disclose
Mauro Mansutti
No relevant relationships to disclose
Gianpiero Fasola
No relevant relationships to disclose
Fabio Puglisi
No relevant relationships to disclose